177Lu-rosopatamab tetraxetan (TLX591) - Telix
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
Ac-225 rosopatamab tetraxetan (CONV01-α) - Dominari Holdings
https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal_2/presentation
 
A. Holmes1; A.B. Arham1; M. Fatima1; S. Bleve2; P.V. Nuzzo3; T. Okobi4; G. Raab5; R. Geisel6; V. Marulanda Corzo7; A. Patel8; C. Thomas9; Z. Davidson8; J. Nauseef10; A.M. Molina11; C.N. Sternberg12; D.M. Nanus13; J. Osborne7; N.H. Bander14; S.T. Tagawa15
 
Jul 24, 2025
 
Prev Next